Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 7/20 | 0.44 |
| ▸ | CPA1 | P15085 | 1/20 | 0.43 |
| ▸ | ACACB | O00763 | 3/20 | 0.42 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.39 |
| ▸ | CPB1 | P15086 | 1/20 | 0.39 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.38 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.38 |
| ▸ | GPR142 | Q7Z601 | 1/20 | 0.37 |
| ▸ | XDH | P47989 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7468244 | 0.81 | HRH3 (0.40) | HRH3CYP19A1CPA1ACACB | |
| SCHEMBL7086614 | 0.80 | CPA1 (0.51) | HRH3CYP19A1CPA1ACACBCPB2 | |
| SCHEMBL7053727 | 0.79 | CPA1 (0.71) | HRH3CYP19A1CPA1CPB2CPB1 | |
| Hydrochloric Acid SCHEMBL8495732 | 0.78 | CPA1 (0.69) | HRH3CYP19A1CPA1CPB2CPB1 | |
| SCHEMBL7703567 | 0.76 | HRH3 (0.55) | HRH3CYP19A1CPA1CPB2CPB1 | |
| SCHEMBL7703563 | 0.76 | HRH3 (0.55) | HRH3CYP19A1CPA1 | |
| Hydrochloric Acid SCHEMBL8133317 | 0.76 | KMT2A (0.47) | — | |
| Hydrochloric Acid SCHEMBL7474426 | 0.75 | HRH3 (0.54) | HRH3CYP19A1CPA1CYP11B1CYP11B2 | |
| SCHEMBL8506342 | 0.71 | CYP19A1 (0.54) | HRH3CYP19A1CPA1 | |
| SCHEMBL7156162 | 0.71 | CYP19A1 (0.42) | HRH3CYP19A1CPA1CPB2CPB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6384061-B1 | HYDANTOIN COMPOUNDS REPRESENTED BY FORMULA (I) WHICH SHOWS AN INHIBITORY ACTIVITY AGAINST FARNESYL TRANSFERASE, AND THUS CAN BE USED AS AN ANTI-CANCER AGENT, OR PHARMACEUTICALLY ACCEPTABLE SALTS | LG CHEMICAL LTD. (KR) | 2002-05-07 | — | — | US | disclosed |
| EP-1000036-A1 | HYDANTOIN DERIVATIVES HAVING AN INHIBITORY ACTIVITY FOR FARNESYL TRANSFERASE | LG CHEMICAL LIMITED (KR) | 2000-05-17 | — | — | EP | disclosed |
| WO-1999005117-A1 | HYDANTOIN DERIVATIVES HAVING AN INHIBITORY ACTIVITY FOR FARNESYL TRANSFERASE | LG CHEMICAL LTD. (KR) | 1999-02-04 | — | — | WO | disclosed |